Wednesday, 9 January 2019

ClinicalGastro2019 #Gastroenterology #Hepatology #CallForAbstractSpeaker | Poster | Group Participation 
Registration starts from $199 
Attain your early bird discount by submitting the abstract 
For more visit: https://bit.ly/2jj4hPa


Tuesday, 18 December 2018

#ClinicalGastro2019
#Callforabstract #Gastroenterology #Hepatology #Liver #London#DigestiveDisease 
Speaker | Poster | Group participation
Attain special offer on Group participation and For student participators
For more visit : https://bit.ly/2jj4hPa


Monday, 10 December 2018

#ClinicalGastro2019 #Liver #LiverFunctionTest 
#Liver function tests , also referred to as a #hepatic panel, are groups of #blood tests that provide information about the state of a #patient's liver. 
These tests include prothrombin time (PT/INR), aPTT, albumin, bilirubin (direct and indirect), and others. The liver transaminases aspartate transaminase (AST or SGOT) and alanine transaminase (ALT or SGPT) are useful biomarkers of liver injury in a patient with some degree of intact liver function. Most liver diseases cause only mild symptoms initially, but these diseases must be detected early. Hepatic (liver) involvement in some diseases can be of crucial importance. This testing is performed on a patient's blood sample. Some tests are associated with functionality (e.g., albumin), some with cellular integrity (e.g., transaminase), and some with conditions linked to the biliary tract (gamma-glutamyl transferase and alkaline phosphatase). Several biochemical tests are useful in the evaluation and management of patients with hepatic dysfunction. These tests can be used to detect the presence of liver disease, distinguish among different types of liver disorders, gauge the extent of known liver damage, and monitor the response to treatment. Some or all of these measurements are also carried out (usually about twice a year for routine cases) on those individuals taking certain medications, such as anticonvulsants, to ensure that the medications are not adversely impacting the person's liver. 

For more Visit : https://bit.ly/2jj4hPa
Abstract submission link : https://bit.ly/2Lm1yBd


Wednesday, 28 November 2018

#ClinicalGastro2019 #Gallbladder #Gastro #Hepatology Call for Abstract 
June 19-20, 2019 | London, UK
For more visit : https://bit.ly/2jj4hPa
Abstract submission : https://bit.ly/2Lm1yBd


Tuesday, 27 November 2018

Thursday, 22 November 2018

#ClinicalGastro2019 #Gastroenterology #Hepatology #DigestiveDiseases
Call for abstract | Speaker | Delegate | Poster | Group participation 
For more visit : https://bit.ly/2jj4hPa 


A digestive disease is any health problem that occurs in the digestive tract. Conditions may range from mild to serious. Some common problems include cancer, irritable bowel syndrome, and lactose intolerance.
Other digestive diseases include:
  • Gallstones, cholecystitis, and cholangitis
  • Rectal problems, such as anal fissure, hemorrhoids, proctitis, and rectal prolapse
  • Esophagus problems, such as stricture (narrowing) and achalasia and esophagitis
  • Stomach problems, including gastritis, gastric ulcers usually caused by Helicobacter pylori infection and cancer
  • Liver problems, such as hepatitis B or hepatitis C, cirrhosis, liver failure, and autoimmune and alcoholic hepatitis
  • Pancreatitis and pancreatic pseudocyst
  • Intestinal problems, such as polyps and cancer, infections, celiac disease, Crohn disease, ulcerative colitis, diverticulitis, malabsorption, short bowel syndrome, and intestinal ischemia
  • Gastroesophageal reflux disease (GERD), peptic ulcer disease, and hiatal hernia

Wednesday, 21 November 2018

#ClinicalGastro2019 #Hepatology 
#London #gastroenterology 
Call for Abstract | Young Research Forum | Attain Special discount on Student Participation 
June 19-20, 2019 | London, UK
For more visit : https://gastro.cmesociety.com/


ClinicalGastro2019   # Gastroenterology   # Hepatology   # CallForAbstract Speaker | Poster | Group Participation  Registration starts from...